Why are our services free for patients and physicians?

dylan 11 Jan 2024

1 mins read

share this post

We are dedicated to removing practical barriers for patients and physicians. That’s why our services are always provided free of charge; they include:

offering information about clinical trials and expanded access programs.
supporting physicians with the expanded access application process worldwide.

We charge BioPharma companies for our services, which include supporting clinical trial recruitment and managing international expanded access programs, logistics, quality management, distribution, and real-world data collection.

For physicians and their patients, myTomorrows ensures free and agnostic access to information about all potential pre-approval options, regardless of our collaborations with BioPharma companies.

share this post

dylan 11 Jan 2024

Stay Up to Date

Signup to our newsletter for updates

more articles

view all blogs

From Symptoms to Treatment: A Guide to Brain Tumours

myTomorrows Team

27 Sep 2024

10 mins read

Navigating Becker Muscular Dystrophy: Symptoms, Diagnosis, and Treatment Options

myTomorrows Team

27 Sep 2024

8 mins read

disabled-boy-in-a-wheelchair-enjoying-the-day-outdoors

Living with Duchenne Muscular Dystrophy: Treatment and Care Essentials

myTomorrows Team

27 Sep 2024

11 mins read

From Diagnosis to Treatment: Managing Limb-Girdle Muscular Dystrophy

myTomorrows Team

17 Sep 2024

11 mins read

myTomorrows and CureLGMD2i Foundation Partnership

myTomorrows and the CureLGMD2i Foundation Partner to Ease Access to Clinical Trials for Patients with Limb Girdle Muscular Dystrophy Type 2I/R9

myTomorrows Team

4 Sep 2024

4 mins read

The Mighties at myTomorrowland 2024

myTomorrows Team

28 Aug 2024

3 mins read

myTomorrows and Pancreatic Cancer Europe Partnership

myTomorrows and Pancreatic Cancer Europe Partner to Support Pancreatic Cancer Patients in Accessing Clinical Trials

myTomorrows Team

27 Aug 2024

4 mins read

Group of physicians investigating new therapies for Type 1 Diabetes

Emerging Treatments for Type 1 Diabetes

myTomorrows Team

14 Aug 2024

6 mins read

Diversity, Equity and Inclusion, group of friends

Building Effective Diversity, Equity, and Inclusion Strategies in Clinical Trial Recruitment

myTomorrows Team

6 Aug 2024

9 mins read

myTomorrows Appoints AstraZeneca Executive Vice President Iskra Reic to its Board of Directors

myTomorrows Team

31 Jul 2024

3 mins read